North American Business Opportunities

Partnering with Apotex – North America

One in five pharmaceutical prescriptions in Canada is filed with an Apotex product, making us a market share leader in the region. In the USA, for the products which Apotex competes in, we have +30% market share.

If you are a pharmaceutical company engaged in the following pharmaceutical development programs Apotex aspires to become your Partner of Choice and wants to hear from you.

Early-to-market and limited competition opportunities

first-to-file/ race-to-market
non-infringing API and/or formulations
NCE-1s
Currently approved and/or filed products
Contract development and/or manufacturing
New Technologies

Inhalation

Dry Powder Inhalers
Metered Dose Inhalers

Injectables

Nano particles
Carbapenems
Depots/ Long Acting injectables
Hormones
Liposomal
Peptides
Lyophilized
Penicillins
Semi-Synthetic Penicillins

Topicals

Creams
Gels
Ointments
Lotions

Ophthalmics

Ointments and gels

Orals

Scheduled products
Orodispersable
Hormones
Buccal/transmucosals
Soft and Hard gelatin capsules

Over-the-counter (OTC) products